CatalystWireBeta

Holding(s) in Company

In brief · summary, not quotable

Physiomics plc announced that Robert McFadden now holds 13,678,940 ordinary shares, representing 3.02% of the company's issued share capital, following a market purchase on August 18, 2026, at 0.47 pence per share. This direct interest signifies a notable stake in the mathematical modelling and data science company.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your PYC notes

Holding in Company

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, announces that it was notified on 20 August 2026 by Robert McFadden that as of 18 August 2026 he holds 13,678,940 ordinary shares of 0.4 pence each in the Company representing 3.02% of the Company's issued share capital, following a market purchase at 0.47 pence per share. The interest is held directly.

For more information about Physiomics and its services, please visit www.physiomics.co.uk.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note